4.5 Article

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

A multi-center study of fidaxomicin use for Clostridium difficile infection

Dhara N. Shah et al.

SPRINGERPLUS (2016)

Article Immunology

Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection

Charlesnika T. Evans et al.

CLINICAL INFECTIOUS DISEASES (2015)

Article Critical Care Medicine

Fulminant Clostridium difficile colitis: Prospective development of a risk scoring system

Gwendolyn M. van der Wilden et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2014)

Review Pharmacology & Pharmacy

Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance

Kathleen Mullane

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2014)

Review Gastroenterology & Hepatology

Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

Christina M. Surawicz et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Article Urology & Nephrology

Renal Impairment and Clinical Outcomes of Clostridium difficile Infection in Two Randomized Trials

Kathleen M. Mullane et al.

AMERICAN JOURNAL OF NEPHROLOGY (2013)

Article Gastroenterology & Hepatology

Clostridium difficile and inflammatory bowel disease: Role in pathogenesis and implications in treatment

Orna Nitzan et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Article Immunology

Antimicrobial Activities of Fidaxomicin

Ellie J. C. Goldstein et al.

CLINICAL INFECTIOUS DISEASES (2012)

Article Immunology

Current Status of Clostridium difficile Infection Epidemiology

Fernanda C. Lessa et al.

CLINICAL INFECTIOUS DISEASES (2012)

Review Infectious Diseases

Consequences of Clostridium difficile infection: understanding the healthcare burden

E. Bouza

CLINICAL MICROBIOLOGY AND INFECTION (2012)

Article Public, Environmental & Occupational Health

Mortality and Clostridium difficile infection: a review

Brett G. Mitchell et al.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2012)

Article Medicine, General & Internal

Fidaxomicin versus Vancomycin for Clostridium difficile Infection

Thomas J. Louie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Microbiology

In vitro activities of OPT-80 and comparator drugs against intestinal bacteria

SA Finegold et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)